Results 121 to 130 of about 27,813 (176)

Incidence and Determinants of Implantable Cardioverter-Defibrillator Therapy With Loss of and Impaired Consciousness. [PDF]

Pacing Clin Electrophysiol
Noordman ABP, Rienstra M, Blaauw Y, Mulder BA, Groenveld H, Maass AH.   +5 more
europepmc   +1 more source

Surgical extravascular implantable cardioverter-defibrillator lead implant when transvenous therapy is undesirable. [PDF]

HeartRhythm Case Rep
Bik A, Römers H, Balt J, Daeter E, Swaans M, Boersma L.   +5 more
europepmc   +1 more source

Transvenous and subcutaneous implantable cardioverter-defibrillator in arrhythmogenic cardiomyopathy: insights from a single-centre experience. [PDF]

Europace
Migliore F, Pittorru R, Cipriani A, Winnicki G, Zancanaro G, Rosso J, Azzolin V, De Lazzari M, Rizzo A, Rigato I, Martini M, Brizzi LF, Metra M, Marra MP, Bauce B, Corrado D.   +15 more
europepmc   +1 more source

Extravascular implantable cardioverter-defibrillator implantation strategies following transvenous or subcutaneous device infections: a case series. [PDF]

Eur Heart J Case Rep
Ono S, Oka S, Wada M, Ishibashi K, Wakamiya A, Ueda N, Nakasuka K, Kusano K.   +7 more
europepmc   +1 more source

Impaired sinus rate behaviour during ventricular arrhythmia is associated with adverse outcomes in implantable cardioverter-defibrillator recipients. [PDF]

Europace
Blondeel M, Goris S, Goethals E, Vermeiren M, Ingelaere S, Vörös G, Rosseel T, Garweg C, Haemers P, Ector J, Willems R, Robyns T, De Potter T, Vandenberk B.   +13 more
europepmc   +1 more source

Audible alarm from an implantable cardioverter defibrillator- unravelling the cause. [PDF]

Indian Pacing Electrophysiol J
Kodliwadmath A, Sridhar P, Narayanan K.
europepmc   +1 more source

The Dutch Implantable Cardioverter-Defibrillator Decision Aid in Clinical Practice: A Stepped-Wedge Randomized Controlled Trial. [PDF]

Med Decis Making
Yilmaz D, Egorova AD, Grauss R, Spierenburg HAM, Venooy K, van Woerkens LPM, Robles de Medina R, Schalij MJ, van Erven L.   +8 more
europepmc   +1 more source

Midterm Efficacy of SubcutAneous Implantable CardioVErter-Defibrillator in ≤ 18 Year-Old CHILDREN (SAVE CHILDREN-II Registry). [PDF]

J Arrhythm
Mori H, Nabeshima T, Nagaoka K, Fukunaga H, Hayashi H, Inaba O, Isonaga Y, Asano S, Nitta J, Watanabe S, Otsuki S, Suzuki H, Fukaya H, Kishihara J, Chisaka T, Higaki T, Okada A, Kobayashi H, Sekihara T, Oka T, Sato S, Yoshino K, Kondo H, Takahashi N, Kato K, Miura M, Maeda J, Tamura S, Ikeda K, Goto H, Murakami T, Wada T, Takamuro M, Suzuki T, Ishida Y, Sasaki S, Nishimura T, Takigawa M, Matsuura T, Imamura T, Shizuta S, Fukunaga M, Kuroda M, Hojo R, Fukamizu S, Suzuki H, Yoshida Y, Morishima I, Kuraishi K, Nishihara E, Naruse Y, Sato T, Aizawa Y, Nishizaki K, Nakamura K, Nuruki N, Yoshinaga M, Ikeya Y, Okumura Y, Muraji S, Kondo Y, Nakano M, Kito M, Inden Y, Higuchi S, Kinjo T, Matsumoto K, Narita M, Sasaki W, Naganuma T, Kawano D, Tanaka N, Matsumoto K, Kojima T, Ikeda Y, Kato R, Sumitomo N.   +76 more
europepmc   +1 more source

Low defibrillation threshold in pediatric patients with subcutaneous implantable cardioverter defibrillator: Implications for a smaller generator? [PDF]

HeartRhythm Case Rep
de Veld JA, van der Stuijt W, Pepplinkhuizen S, Blom NA, Smeding L, Kooiman KM, Knops RE.   +6 more
europepmc   +1 more source

Public Electric Baths in Japan: A Risk of Inappropriate Implantable Cardioverter-Defibrillator Shock. [PDF]

J Arrhythm
Ido T, Nakashima T, Yamaura M, Takahashi S, Aoyama T.   +4 more
europepmc   +1 more source